Scopus Eşleşmesi Bulundu
5
Atıf
21
Cilt
2553-2562
Sayfa
Özet
Background: Prostate cancer (PCa) has the second-highest morbidity and mortality rates in men. Possessing facile surface chemistry and unique optical properties make silica nanoparticles(SiO2-NPs) promis-ing cancer therapy materials. Objective: This study aimed to investigate the effects of SiO2-NPs and their derivatives, including SiNP-NH2, SiNP-Cl, and SiNP-SH against PCa and clarify their molecular mechanism on cell death, gene, and protein ex-pressions. Methods: Following the synthesis and derivation of SiO2-NPs, their characterization was carried out using TEM, DLS, BET, and FT-IR. Cytotoxic properties of the compounds were investigated against different human cancerous cells; including HUH-7, A549, DLD-1, HeLa, NCI-H295R, and PC-3, as well as human healthy epithelium cell line PNT1A. Results: SiNP-NH2, SiNP-Cl, and SiNP-SH dose-dependently inhibited the proliferation of PC-3 cells with an IC50 value as 55.46 μg/mL, 55.09 μg/mL and 72.89 μg/mL, respectively. SiNP-SH significantly(p<0.0001) inhibited metastasis and invasion of PC-3 cells(20.4% and 46.7%, respectively), and significantly(p<0.0001) increased early apoptosis(32.3%) when compared with non-treated cells. Protein and mRNA expressions of BcL-2, Bax, caspase-3, caspase-9, caspase-12, p53, Smad-4, Kras, and Nf-ĸB were also altered following the treatment of SiO2-NPs and its derivatives. Conclusion: Our results demonstrated that-SH functioned SiO2-NPs can prevent the proliferation of human PCa by increasing apoptosis by up-regulating gene and protein expression of p53(TP53) as well as caspase-3, caspase-9, and caspase-12 in the apoptotic pathway. Besides, the increased level of Smad-4 has also implicated the decreased cell proliferation. Hence, low sized SiNP-SH nanoparticles might be a suitable candidate for the treatment of human PCa.
Web of Science Eşleşmesi Bulundu
5
WoS Atıf
21
Cilt
Article
Belge Türü
Kaynak: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
· s. 2553-2562
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 5.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2021 yılı verileri
Anti-Cancer Agents in Medicinal Chemistry
Q3
SJR Quartile
0,403
SJR Skoru
113
H-Index
Kategoriler: Molecular Medicine (Q3) · Pharmacology (Q3) · Cancer Research (Q4)
Alanlar: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics
Ülke: United Arab Emirates
· Bentham Science Publishers
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Anti-Cancer Agents in Medicinal Chemistry
ISSN
1871-5206
Yıl
2021
/ 12. ay
Cilt / Sayı
21
/ 18
Sayfalar
2553 – 2562
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q3
Teşvik Puanı
5,40
· YÖKSİS Akademik Teşvik
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
3 kişi
Erişim Türü
Basılı+Elektronik
Alan
Fen Bilimleri ve Matematik Temel Alanı
Kimya
Fiziksel Kimya
Yüzey Kimyası
YÖKSİS Yazar Kaydı
Yazar Adı
DURMUŞ İREM MUKADDES, DEVECİ İLYAS, KARAKURT SERDAR
YÖKSİS ID
5644301